Pharmacologic treatment for PTSD-related nightmares MOA?

Pharmacologic treatment for PTSD-related nightmares MOA?

• A. Propranolol; beta blocker
• B. Prazosin; alpha-1 antagonist
• C. Fluoxetine; SSRI
• D. Diazepam; GABA-A agonist

Answer: (B)

PTSD-related nightmares are driven by heightened noradrenergic activity during sleep, especially in REM, which amplifies fear memories and arousal at night. Blocking this pathway at the alpha-1 receptor level directly reduces the exaggerated arousal that fuels those distressing dreams. Prazosin is an alpha-1 adrenergic receptor antagonist. By blocking central and peripheral alpha-1 receptors, it dampens the noradrenergic signaling that surges during sleep, leading to fewer and less intense nightmares and overall better sleep quality. Other drugs don’t target this sleep-specific noradrenergic mechanism as effectively. Propranolol is a beta-blocker and can influence memory reconsolidation in some contexts, but it’s not the standard approach for treating PTSD-related nightmares. Fluoxetine, an SSRI, helps broader PTSD symptoms but does not specifically reduce nocturnal nightmares via alpha-1–mediated pathways. Diazepam acts on GABA-A but carries risks of dependence and doesn’t reliably improve PTSD-nightmare symptoms.

PTSD-related nightmares are driven by heightened noradrenergic activity during sleep, especially in REM, which amplifies fear memories and arousal at night. Blocking this pathway at the alpha-1 receptor level directly reduces the exaggerated arousal that fuels those distressing dreams.

Prazosin is an alpha-1 adrenergic receptor antagonist. By blocking central and peripheral alpha-1 receptors, it dampens the noradrenergic signaling that surges during sleep, leading to fewer and less intense nightmares and overall better sleep quality.

Other drugs don’t target this sleep-specific noradrenergic mechanism as effectively. Propranolol is a beta-blocker and can influence memory reconsolidation in some contexts, but it’s not the standard approach for treating PTSD-related nightmares. Fluoxetine, an SSRI, helps broader PTSD symptoms but does not specifically reduce nocturnal nightmares via alpha-1–mediated pathways. Diazepam acts on GABA-A but carries risks of dependence and doesn’t reliably improve PTSD-nightmare symptoms.